Literature DB >> 9524509

Failed hip prostheses in hemodialysis patients. Amyloid deposition at the bone-implant interface in 4 cases.

N Umeda1, M Saito, H Miki, M Yoneda, K Yamaguchi, N Shimizu, Y Kobayashi.   

Abstract

4 hemodialysis patients with failed bipolar hip prostheses underwent 6 revision arthroplasties. Their average age was 55 years, the average duration of hemodialysis was 14 years and the average interval from the primary arthroplasty to revision was 7 years. The interface membranes revealed amyloid deposits in all specimens. There were few polyethylene wear particles, and cement debris or foreign body reactions were rare. It appears that amyloid may cause osteolysis and early prosthetic loosening.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9524509     DOI: 10.3109/17453679809002347

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  4 in total

1.  Chronic renal failure due to amyloid nephropathy caused by chronic infection after total hip replacement.

Authors:  Shinsuke Nishimura; Tomoji Matsumae; Yuji Murakami; Yasuhiro Abe; Yoshie Sasatomi; Ikufumi Nagayoshi; Kazuo Ueda; Hitoshi Nakashima
Journal:  CEN Case Rep       Date:  2014-04-16

2.  Hip hemiarthroplasty for femoral neck fractures in end-stage renal disease patients on dialysis compared to patients with late-stage chronic kidney disease.

Authors:  Benjamin Tk Ding; Abhishek Shinde; Kelvin G Tan
Journal:  Singapore Med J       Date:  2019-08       Impact factor: 1.858

3.  Uncemented total hip arthroplasty in chronic hemodialysis patients.

Authors:  Wei-Chun Li; Chun-Hsiung Shih; Steve W Ueng; Hsin-Nung Shih; Mel S Lee; Pang-Hsin Hsieh
Journal:  Acta Orthop       Date:  2010-04       Impact factor: 3.717

4.  The Effect of Renal Transplantation in End-Stage Renal Failure Patients Undergoing Total Hip Replacement.

Authors:  Winston Shang Rong Lim; Kelvin Guoping Tan; Andy Khye Soon Yew; Seng Jin Yeo
Journal:  Indian J Orthop       Date:  2019 May-Jun       Impact factor: 1.251

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.